Siemens Healthineers AG (OTCMKTS:SMMNY) Receives Consensus Recommendation of “Buy” from Brokerages

Siemens Healthineers AG (OTCMKTS:SMMNY) has been assigned a consensus rating of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation, two have assigned a buy recommendation and three have assigned a strong buy recommendation to the company.

SMMNY has been the subject of a number of recent research reports. Zacks Research cut shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Friday, December 12th. Deutsche Bank Aktiengesellschaft cut shares of Siemens Healthineers from a “buy” rating to a “hold” rating in a research report on Thursday, December 4th. Finally, Royal Bank Of Canada assumed coverage on Siemens Healthineers in a research report on Wednesday, December 17th. They issued a “moderate buy” rating for the company.

Siemens Healthineers Trading Up 1.1%

OTCMKTS SMMNY opened at $26.25 on Tuesday. The stock has a 50 day moving average price of $26.05 and a 200-day moving average price of $26.87. Siemens Healthineers has a one year low of $23.28 and a one year high of $30.19.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.